๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ
Cover of Blood Country: The Second Byron Tibor Novel

Blood Country: The Second Byron Tibor Novel

โœ Scribed by Black, Sean

Book ID
108894342
Year
1995
Tongue
English
Weight
137 KB
Series
Byron Tibor 2
Category
Fiction

No coin nor oath required. For personal study only.

โœฆ Synopsis

Overview: The second novel in the award-nominated Byron Tibor series.

๐Ÿ“œ SIMILAR VOLUMES

cover
Blood Country: The Second Byron Tibor Novel
โœ Black, Sean ๐Ÿ“‚ Fiction ๐Ÿ“… 2015 ๐ŸŒ English โš– 138 KB

The second novel in the award-nominated Byron Tibor series.๏ฟฝ Having fled his home in New York, and still hunted by the Federal government, special forces veteran Byron is forced to intervene when he stumbles across unsettling events in a small Texas border town.๏ฟฝ The first novel in the series, Pos

3 Action-Packed Byron Tibor Thrillers: P
3 Action-Packed Byron Tibor Thrillers: Post / Blood Country / Winter's Rage
โœ Sean Black ๐Ÿ“‚ Fiction ๐Ÿ“… 2017 ๐Ÿ› Sean Black Digital ๐ŸŒ English โš– 403 KB

All-American hero, burned out veteran, lone bringer of vigilante justice. Follow Byron Tibor's epic journey through these three beautifully crafted thrillers by award-nominated author, Sean Black. POST (Nominated for the International Thriller Writers Award) Exhausted by years of combat, and h

Cenderitide (CD-NP), a novel peptide des
Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure
โœ Lisa C Costello-Boerrigter; John A Schirger; Wayne L Miller; Guido Boerrigter; H ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› BioMed Central ๐ŸŒ English โš– 135 KB

Costello-Boerrigter et al.: Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure.